$GMHS

Gamehaus Holdings Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Requirement

Gamehaus Holdings Inc. (Nasdaq: GMHS) said Nasdaq notified it that its Class A ordinary shares’ closing bid fell below $1.00 for 30 straight business days, triggering Nasdaq Rule 5550(a)(2). The company has until Jan. 6, 2027 to regain compliance by closing at least $1.00 for 10 days, with possible extension.

Original reporting
Published Jul 13, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$GMHS
Neutral
medium confidence
Mentioned
$GMHS
Relevance
6/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$GMHSNeutralMed
01

Why it matters

The company has 180 calendar days to cure by achieving at least $1.00 closing bid for 10 consecutive business days. If not cured by January 6, 2027, it may seek an additional 180-day period by meeting other continued listing requirements and providing notice of intent to cure.

02

Market read

Traders should treat the $1.00 bid threshold as a near-term catalyst for volatility and risk pricing through the compliance window.

03

What to watch

The article does not state current bid/price levels or liquidity; actual trading behavior around $1.00 will depend on market demand and whether the company can sustain the required 10 consecutive business days above $1.00.

Relevance 6/10Novelty 6/10Timing: today’s Nasdaq notice starts a compliance timeline ending January 6, 2027.

Background

Nasdaq Listing Rule 5550(a)(2) requires a minimum $1.00 closing bid price; failure for 30 consecutive business days triggers a compliance notice.

Company-level read

Ticker impact

$GMHSNeutralMedium confidence
Context

Gamehaus received a Nasdaq notice that its closing bid fell below $1.00 for 30 straight business days, triggering a compliance clock.

Expected impact

Choppy trading risk, with traders watching for any sustained move back above $1.00 to avoid delisting escalation.

Evidence & confidence

The notice has no immediate trading effect, but it establishes a 180-day cure period to regain compliance, making the $1.00 level a key technical and risk-management reference.

Market effects

Highlights ongoing Nasdaq bid-price compliance pressure for micro/small-cap issuers, which can spill into sentiment for similar low-priced names.

Limited, as the event is company-specific on Nasdaq.

Low, since it is a US listing compliance matter with no stated international operational impact.

Counterpoint

Because the notice has no immediate effect and the company has a defined cure path, the market may over-discount the risk until the cure period nears.

Key entities

  • Gamehaus Holdings Inc.

    Nasdaq-listed mobile game publisher that received the minimum bid price compliance notice.

  • Nasdaq Stock Market LLC

    Exchange that issued the notification under Listing Rule 5550(a)(2) and Rule 5810(c)(3)(A).

Related articles

$GMHSMed

Gamehaus Holdings Inc. (GMHS): Financial results for Q4 2026

Gamehaus Holdings Inc. (GMHS) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026 SHANGHAI, September 8, 2026 /PRNewswire/ — Gamehaus Holdings Inc. (“Gamehaus” or the “Company”) (Nasdaq: GMHS), a technology-driven mobile game pub

$AXONHighAI 9/10

Axon Announces Pricing of $1.0 Billion Offering of 0% Convertible Senior Notes Due 2031

Axon Enterprise (AXON) priced a $1.0 billion offering of 0% convertible senior notes due 2031, with an option for underwriters to purchase an additional $150 million. Net proceeds, after expenses, are expected to be $986.0 million (or $1,134.3 million if the over-allotment option is fully exercised). Axon plans to use $99.9 million (or $114.9 million with full over-allotment) for capped call transactions and the rest for general corporate purposes, including potential acquisitions. The notes are

$NVDAMedAI 8/10

Nvidia Spent $26 Billion on Buybacks and Dividends in a Single Quarter. Its Board Is Betting Today's Profits Last 3 More Years.

Nvidia (NVDA) returned $26.0B to shareholders in Q2 2027, exceeding its $21.3B free cash flow. The company increased its dividend and authorized $80B for buybacks, with $99B remaining. Nvidia's revenue grew 106% YoY to $96.2B, and net income rose 126% to $59.7B. Management expects profits to sustain these returns for at least three years.

$GMLow

GM, Bedrock seek millions in tax incentives for RenCen project

GM and Bedrock seek $547.93M in incentives for a $2.24B RenCen project. The plan includes demolishing towers, creating park space, and generating jobs. Officials say incentives are needed due to rising construction costs. GM is contributing $250M, while Gilbert has pledged $1B. Approvals are sought by 2026, with construction potentially starting in April 2024.

$ORCLHighAI 8/10

Oracle Hits Workers With Second Wave of 6 AM Emails as Restructuring Bill Climbs to $2.8B

Oracle sent a second wave of 6 AM termination emails to employees globally, coinciding with a disclosed $2.8B restructuring cost, up from $2.1B. The company reported record Q1 FY27 revenue of $19.3B, up 30% YoY, with cloud revenues rising 62%. Oracle's restructuring plan continues, with estimates suggesting 7,000-10,000 jobs cut, including significant reductions in India. The company's capital expenditures totaled $28.5B in Q1, with free cash flow at -$5.4B.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.